In recent years, our industry has focused on the critical need to improve the therapeutic journey for patients taking complex specialty medications. Too often, however, delays in therapy initiation can extend days, weeks, or longer, depending on the level of administrative and financial hurdles.
Reimbursement challenges can cause lengthy delays in therapy initiation for patients with life-threating diseases. However, improving outcomes is more than just overcoming barriers to access. Many patients, already at an increased stress level because of the seriousness of their disease, may experience increased anxiety when beginning a new treatment regimen, leading to a decrease in adherence.
Moving pharmaceutical products from development into commercialization is no small feat. Doing so for a rare disease and improving speed to therapy is even more challenging. Check out our case study video to learn what an integrated program model can do for you and your patients with rare diseases.
When it comes to optimizing Reimbursement Hub models, overcoming barriers to access and decreasing time-to-fill are top priorities. At UBC, we not only focus on the operational efficiencies of your programs, but we listen, wholeheartedly, to the stories of your patients — and we continually go above and beyond to help them.
Clients and service providers working together to deliver exceptional support to patients can lead to improved health outcomes as well as an improved bottom line.
Sound like a tall order? It’s really not when manufacturers and service providers align on goals and work together to put patients’ needs first. This business model helped a UBC client exceed its stretch sales target by $10 million last year.
At UBC, I work in a program that helps patients breathe easier — literally. If at any time we can get medication to a patient one day sooner, that’s one more day they can breathe easier.
Compassion is good business. That’s why we put the patient at the center of all of our commercial services, including Reimbursement Hubs.
On February 28, patient communities around the world will celebrate Rare Disease Day to raise awareness about rare diseases and their impact on patients’ lives.
In a world of mounting cost pressures, providing effective patient services continues to be a key consideration for manufacturers of specialty medications. The right Hub design can optimize a manufacturer’s investment and lead to healthy (and happy) patients.
This week pharmaceutical and biotech professionals gathered to learn and network at Pinsonault’s Managed Markets Summit. The Fall 2014 Summit focused on the key topics in today’s marketplace, including the Affordable Care Act, Health Insurance Exchange, and, of course, Specialty Pharmacy. UBC once again brought our experts to share their knowledge. In case you missed it, our sessions included:
Specialty Pharmacy Contracting
Charlie Bell, Director, New Business Development